CoChat

Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2

Bray, Cara, Wright, David, Haupt, Sonja, Thomas, Sharyn, Stauss, Hans, Zamoyska, Rose · 2018 · Frontiers in Immunology
Cited by 28

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.02595

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. Gregersen, 2006, PTPN22: setting thresholds for autoimmunity, Semin Immunol., 18, 214, 10.1016/j.smim.2006.03.009 · DOI · Paper page
  2. Hasegawa, 2004, PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells, Science, 303, 685, 10.1126/science.1092138 · DOI · Paper page
  3. Cloutier, 1996, Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells, EMBO J., 15, 4909, 10.1002/j.1460-2075.1996.tb00871.x · DOI · Paper page
  4. Salmond, 2014, The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals, Nat Immunol., 15, 875, 10.1038/ni.2958 · DOI · Paper page
  5. Zhang, 2011, The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness, Nat Genet., 43, 902, 10.1038/ng.904 · DOI · Paper page
  6. Dai, 2013, A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models, J Clin Invest., 123, 2024, 10.1172/JCI66963 · DOI · Paper page
  7. Rieck, 2007, Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes, J Immunol., 179, 4704, 10.4049/jimmunol.179.7.4704 · DOI · Paper page
  8. Vang, 2005, Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant, Nat Genet, 37, 1317, 10.1038/ng1673 · DOI · Paper page
  9. Lefvert, 2008, PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis, J Neuroimmunol, 197, 110, 10.1016/j.jneuroim.2008.04.004 · doi:10.1016/j.jneuroim.2008.04.004
  10. Zikherman, 2009, PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background, J Immunol., 182, 4093, 10.4049/jimmunol.0803317 · DOI
  11. Thomas, 2011, Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen, Blood, 118, 319, 10.1182/blood-2010-12-326736 · DOI
  12. Ran, 2013, Genome engineering using the CRISPR-Cas9 system, Nat Protoc., 8, 2281, 10.1038/nprot.2013.143 · DOI · Paper page
  13. Schrum, 2007, High-sensitivity detection and quantitative analysis of native protein-protein interactions and multiprotein complexes by flow cytometry, Sci STKE, 2007, pl2, 10.1126/stke.3892007pl2 · doi:10.1126/stke.3892007pl2
  14. Sood, 2016, Loss of the protein tyrosine phosphatase PTPN22 reduces mannan-induced autoimmune arthritis in SKG Mice, J Immunol., 197, 429, 10.4049/jimmunol.1502656 · DOI
  15. Gallagher, 2018, Peptide antigen concentration modulates digital NFAT1 activation in primary mouse naïve CD8+ T cells as measured by flow cytometry of isolated cell nuclei, Immunohorizons, 2, 208, 10.4049/immunohorizons.1800032 · DOI
  16. Baghbani, 2017, Suppression of protein tyrosine phosphatase PTPN22 gene induces apoptosis in T-cell leukemia cell line (Jurkat) through the AKT and ERK pathways, Biomed Pharmacother., 86, 41, 10.1016/j.biopha.2016.11.124 · DOI
  17. Zheng, 2013, PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant, Diabetes, 62, 896, 10.2337/db12-0929 · DOI
  18. Brownlie, 2012, Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function, Sci Signal., 5, ra87, 10.1126/scisignal.2003365 · DOI · Paper page
  19. Maine, 2012, PTPN22 alters the development of regulatory T cells in the thymus, J Immunol., 188, 5267, 10.4049/jimmunol.1200150 · DOI
  20. Brownlie, 2017, Resistance to TGFβ suppression and improved anti-tumor responses in CD8+ T cells lacking PTPN22, Nat Commun., 8, 1, 10.1038/s41467-017-01427-1 · DOI
  21. Perri, 2017, Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes, PLoS ONE, 12, e0175784, 10.1371/journal.pone.0175784 · DOI
  22. Cohen, 1999, Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp, Blood, 93, 2013, 10.1182/blood.V93.6.2013.406k25_2013_2024 · DOI · Paper page
  23. Wang, 2010, Identification of a variant form of tyrosine phosphatase LYP, BMC Mol Biol., 11, 78, 10.1186/1471-2199-11-78 · DOI
  24. Chang, 2012, PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis, PLoS ONE, 7, e33067, 10.1371/journal.pone.0033067 · DOI
  25. Chang, 2014, Altered expression of protein tyrosine phosphatase, non-receptor type 22 isoforms in systemic lupus erythematosus, Arthritis Res Ther, 16, R14, 10.1186/ar4440 · DOI
  26. Ronninger, 2012, The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls, Genome Med., 4, 2, 10.1186/gm301 · DOI

Cited by

See all 28

Metadata

Authors
Bray, C., Wright, D., Haupt, S., Thomas, S., Stauss, H., & Zamoyska, R.
Venue
Frontiers in Immunology
Published
2018-11-12
Volume
9
ISSN
1664-3224
Cited by
28
References
0

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2. https://app.cochat.ai/papers/10.3389/fimmu.2018.02595
The paper
Bray, C., Wright, D., Haupt, S., Thomas, S., Stauss, H., & Zamoyska, R. (2018). Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.02595

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.